Epigenetics of Alzheimer's and Parkinson's Disease Part A
- 1st Edition, Volume 118 - May 1, 2027
- Latest edition
- Editors: Subashchandrabose Chinnathambi, Ainara Castellanos-Rubio
- Language: English
Epigenetics of Alzheimer's and Parkinson's Disease Part A, published as Volume 118 of the serial Advances in Genetics, provides a focused survey of the epigenetic mechanism… Read more
Description
Description
Epigenetics of Alzheimer's and Parkinson's Disease Part A, published as Volume 118 of the serial Advances in Genetics, provides a focused survey of the epigenetic mechanisms underlying two of the most prevalent neurodegenerative disorders. Contributions from international researchers examine microRNA-based therapeutic strategies, exosome-mediated pathways, noncoding RNA regulation, DNA and histone modifications, and gene-environment-epigenome interactions in Alzheimer's and Parkinson's disease. The volume offers researchers a current reference point for understanding how epigenetic regulation contributes to disease onset and progression, and how these mechanisms might be targeted therapeutically.
Key features
Key features
- Surveys epigenetic mechanisms — miRNA, noncoding RNA, DNA/histone modification — implicated in Alzheimer's and Parkinson's disease
- Covers exosome-mediated pathways and gene-environment-epigenome interactions in neurodegeneration
- Authored by international contributors across genetics, molecular biology, and neuroscience
- Provides a reference point for both mechanistic understanding and emerging epigenetic-targeted therapeutic strategies
- Part of the long-running Advances in Genetics serial, maintaining continuity with established editorial standards
Readership
Readership
Neuroscientists and molecular geneticists studying neurodegenerative disease; epigenetics and RNA biology researchers; clinical researchers investigating Alzheimer's and Parkinson's disease pathogenesis; graduate students and postdoctoral fellows in neurogenetics and epigenetics.
Table of contents
Table of contents
- Therapeutic Intervention of Alzheimer's and Parkinson's Diseases by Targeting miRNAs
- Exosome Pathways in Parkinson's Disease
- Epigenetic Modification in AD/PD
- Noncoding RNAs as Epigenetic Regulators in Parkinson's Disease
- Epigenetic Modification in Alzheimer's Disease
- Gene-Environment-Epigenome Interactions in Alzheimer's and Parkinson's Disease
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 118
- Published: May 1, 2027
- Language: English
About the editors
About the editors
SC
Subashchandrabose Chinnathambi
Subashchandrabose Chinnathambi is Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, Karnataka, India. His scientific interests include physiopathology of neurodegenerative disorders, Tau Cytoskeleton, Tau-GPCR, purinergic and chemokine receptors, Tau stem cells, animal models, neuropharmacology, therapeutic approaches targeting Tau oligomers, and biomarkers for neurodegeneration. He serves on the editorial board for various international cell biology journals and is also a regular invited speaker at a number of meetings and workshops. Dr. Chinnathambi has more than 16 years of research experience in the area of neuroscience and Tau-related research in Alzheimer’s Disease.
AC